New York will seek financial penalties from the family and the disgorgement of “wrongfully obtained profits,” she said at the press conference. The Sacklers have regularly been moving their money out of the company to shield it from possible recovery, according to James.
Other Cases
The Sacklers have also been sued by a group of more than 500 cities and counties, filed in New York, and the state of Massachusetts. The family has denied any wrongdoing in both cases, but the publicity has led some in the art world to protest museums that have received donations from the Sacklers.
About 400,000 Americans have died since 1999 from opioid-related overdoses, with another 130 perishing daily, Massachusetts said in its suit.
The Oklahoma settlement by Purdue and the Sacklers came two months before the scheduled start of a trial against the company, Johnson & Johnson, Teva Pharmaceutical Industries Inc. and other opioid makers. The trial is set for May against companies other than Purdue.
The Drugmaker Defendants in New York’s Case:
J&J, based in New Brunswick, New Jersey, and its Janssen Pharmaceuticals subsidiary. Mallinckrodt Plc, an Irish company headquartered in Staines-Upon-Thames, Britain. Endo International Plc, with global headquarters in Dublin. Teva Pharmaceutical Industries Ltd., with headquarters in Petah Tikva, Israel, and units Cephalon Inc. and Actavis Pharma Inc. Allergan Plc, which is based in Dublin.
The Distributor Defendants:
McKesson Corp., based in San Francisco. AmerisourceBergen Corp., based in Chesterbrook, Pennsylvania. Cardinal Health Inc., based in Dublin, Ohio. Rochester Drug Cooperative Inc., based in Rochester, New York.
This article was provided by Bloomberg News.